EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges

Boyka Markova, Steffen Mayerl iD, Heike Heuer iD

European Thyroid Journal · 2024

DOI: 10.1530/etj-24-0286 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Thyroid Journal, 2024. Verfasst von Boyka Markova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes & Metabolism, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Symporters, Muscle Hypotonia, Thyroid Hormones. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with an inactive thyroid hormone (TH) transporter MCT8 (Allan–Herndon–Dudley Syndrome, AHDS) display severe neurological impairments and motor disabilities, indicating an indispensable function of MCT8 in facilitating TH access to the human brain. Consequently, the CNS of AHDS patients appears to be in a TH deficient state, which greatly compromises proper neural development and function. Another hallmark of this disease is that patients exhibit elevated serum T3 levels, leading to a hyperthyroid situation in peripheral tissues. Several treatment strategies have been developed and evaluated in preclinical mouse models as well as in patients. Here, we discuss these different therapeutic approaches to overcome MCT8 deficiency and summarize the current achievements and challenges in improving brain maturation in the absence of MCT8.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monocarboxylic Acid TransportersSymportersMuscle HypotoniaThyroid HormonesHumansAnimalsMiceX-Linked Intellectual DisabilityMuscular AtrophyBrainDisease Models, AnimalTriiodothyronine

Stichwörter der Autor:innen

Allan–Herndon–Dudley syndromeDITPAMCT8OATP1C1SLC16A2SLCO1C1TRIACgene therapyphenylbutyratethyroid hormone transporter

Substanzen

Monocarboxylic Acid TransportersSymportersThyroid HormonesSLC16A2 protein, humanTriiodothyronine

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetes & Metabolism, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Medical Faculty, University of Duisburg-Essen, Essen, Germany.

ORCID-Profile: Steffen Mayerl, Heike Heuer

Zitieren

APA

Markova, B., Mayerl, S., & Heuer, H. (2024). Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges. European Thyroid Journal. https://doi.org/10.1530/etj-24-0286

Vancouver

Markova B, Mayerl S, Heuer H. Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges. European Thyroid Journal. 2024. doi:10.1530/etj-24-0286

BibTeX
@article{Markova2024,
  author = {Markova, Boyka and Mayerl, Steffen and Heuer, Heike},
  title = {Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges},
  journal = {European Thyroid Journal},
  year = {2024},
  doi = {10.1530/etj-24-0286}
}
Kostenlos starten →